secwatch.observer — SEC 8-K summary
======================================

Issuer:     Moleculin Biotech, Inc. (MBRX)
CIK:        0001659617
Form:       8-K
Filed at:   2025-10-16T23:59:59+00:00
Accession:  0001437749-25-031123
Event type: other_material
Sentiment:  negative
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Moleculin Biotech special meeting: name change proposal fails; warrant issuance approved
--------------------------------------------------------------------------------

- Stockholders rejected name change to Moleculin Inc.; needed majority of 36.7M outstanding shares but only 11.3M voted For.
- Approved issuance of up to 64.9M shares upon exercise of warrants issued Aug 28, 2025 (4.9M For, 1.5M Against).
- Adjournment proposal passed (5.6M For) to allow further proxy solicitation if needed.
- Broker non-votes totaled 8.2M for warrants and adjournment proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925031123/0001437749-25-031123-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1659617/000143774925031123/mbrx20251013_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-031123

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer